Firebrick Pharma Limited (AU:FRE) has released an update.
Firebrick Pharma Limited has announced a new securities issue proposed for September 9, 2024, aiming to issue a maximum of 1.5 million options expiring on September 8, 2027, at $0.09 each. This move, intended to boost the company’s financial position, is awaiting approval for quotation on the ASX under the code FRE.
For further insights into AU:FRE stock, check out TipRanks’ Stock Analysis page.
